期刊文献+

氟康唑预防早产儿侵袭性真菌感染的效果 被引量:8

Preventive effect of Fluconazole prophylaxis on invasive fungous infections of premature infants
原文传递
导出
摘要 目的 探讨氟康唑预防早产儿侵袭性真菌感染的效果。方法 采用回顾性研究的方法,对2008年2月至2013年10月在江门市中心医院住院治疗且符合病例纳入标准的234例早产儿的临床资料进行分析,按照是否使用及口服应用还是静脉应用氟康唑预防早产儿侵袭性真菌感染将患儿分为3组:A 组为未使用氟康唑预防组,B组为口服应用氟康唑预防组[6 mg/(kg·次),隔天 1次],C 组为静脉应用氟康唑预防组[3 mg/(kg·次),每3天1次]。比较 3组侵袭性真菌感染的发生率。结果 A 组 53例,B 组 115例,C 组66例,3组间性别比、出生胎龄、出生体质量、住院天数、静脉营养使用天数、经外周穿刺中心静脉导管置管天数、使用抗生素天数、使用有创机械通气天数比较差异均无统计学意义(P均 〉0.05);其中 A 组、B组、C组侵袭性真菌感染的发生率分别为11.32%(6/53例)、6.96%(8/115例)、0;3组效果不全相同(χ2=7.078,P =0.029),其中A组与B组比较差异无统计学意义(χ2=0.905,P =0.342),C组优于A 组与 B组,差异有统计学意义(P =0.007,0.028)。结论 静脉应用氟康唑预防早产儿侵袭性真菌感染的效果较好,可以作为优先选择。 Objective To explore the preventive effect of Fluconazole on invasive fungous infections in prema- ture infants. Methods Two hundred and thirty-four cases of preterm infants hospitalized in Jiangmen Central Hospital from Feb. 2008 to Oct. 2013 were analyzed by retrospective study. The subjects were divided into 3 groups based on whether Fluconazole was used and it was used orally or intravenously for the prevention of invasive fungous infections in premature infants. The Fluconazole prophylaxis was not given to group A, whereas oral Fluconazole prophylaxis [ 6 mg/( kg · times), every other day ] and intravenous Fluconazole prophylaxis [ 3 mg/ ( kg · times ), once every 3 days ] were applied in group B and group C. The incidence of invasive fungous infections and the clinical effects of Fluconazole on the 3 groups were evaluated and compared. Results The number of cases analyzed in the study were 53, 115 and 66 cases in group A,group B and group C,respectively. There were no significant differences between the 3 groups in terms of gender, gestational age, birth weights, length of hospitalization, intravenous nutrition, and number of peripherally inserted central catheter, antibiotics and invasive mechanical ventilation use days (all P 〉 0.05 ). The inci- dences of invasive fungal infections were 11.32% (6/53 cases) ,6.96% (8/115 cases) and 0 in group A,group B and group C, respectively. The prophylaxis effects between the 3 groups were significantly different (χ^2 = 7. 078, P = 0.029 ). Group A and group B were not significantly different (χ^2 =0.905 ,P =0. 342) ,but group C was better than group A and group B, and the differences were significant (P = 0.007,0.028). Conclusions Prevention of invasive fungous infections by intravenous Fluconazole has good curative effects,and which can be used as the first choice.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2014年第22期1751-1753,共3页 Chinese Journal of Applied Clinical Pediatrics
关键词 氟康唑 真菌 预防 婴儿 早产 Fluconazole Fungus Prophylaxis Infant, newborn
  • 相关文献

同被引文献73

  • 1李平,张山,刘德立.细菌好氧反硝化研究进展[J].微生物学杂志,2005,25(1):60-64. 被引量:70
  • 2李平,张山,郑永良,江月,陈舒丽,邹煜平,刘德立.反硝化真菌-细菌优化组合及其脱氮能力研究[J].环境科学与技术,2006,29(3):9-10. 被引量:12
  • 3Pfaller MA, Castanheira M, Messer SA, et al. Variation in Candida spp . distribution and antifungal resistance rates among bloodstream infection isolates by patient age:report from the SENTRY Antimicrobial Surveillance Program (2008-2009) [J].Diagn Microbiol Infect Dis,2010, 68(3):278-783.
  • 4Neu N, Malik M, Lunding A, et al. Epidemiology of candidemia at a children's hospital, 2002 to 2006 [J]. Pediatr Infect Dis J, 2009, 28: 806-809.
  • 5Pammi M, Holland L, Butler G, et al. Candida parapsilosis is a significant neonatal pathogen:a sys- tematic review and meta-analysis [J]. Pediatr Infect Dis J, 2013, 32(5): 206-216.
  • 6Pfaller M, Neofytos D, Diekema D, et al. Epidemi- ology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance) registry, 2004-2008. Diagn Microbiol Infect Dis, 2012, 74(4): 323-331.
  • 7Spiliopoulou A, Dimitriou G, Jelastopulu E, et al. Neonatal intensive care unit candidemia:epidemiology, risk factors, outcome, and critical review of published- case series. Mycopathologia,2012,173(4):219-228.
  • 8Sardana V, Pandey A, Madan M,et al.Neonatal candidemia:a changing trend. Indian J Pathol Micro- biol 2012,55(1):132-133.
  • 9Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for candidemia in pediatric in- tensive care unit patients: implications for prevention [J]. Clin Infect Dis 2010,51(5):38-45.
  • 10Conde--Rosa A, Amador R, Perez Torres D, et al. Candidemia distribution,associated risk factors, and attributed mortality at a university--based medi- cal center [J].P R Heahh Sc i J.2010.29(1): 26-29.

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部